Senesco Technologies, Inc. Announces the Appointment of Dr. Harlan W. Waksal, M.D. as Chairman of the Board of Directors and the Addition of Mr. Warren J. Isabelle, CFA to its Board of Directors
DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec(R) in GI GVHD
CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement
Pasteuria Bioscience Receives EPA Registration for Nematode Control
Diamyd(R) Phase III Study Approved for Younger Patients in the US
Caliper Life Sciences to Webcast Investor Session of Open House
Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content. Terms and conditions, including restrictions on redistribution, apply. Copyright © 1996-2009 PR Newswire Association LLC. All Rights Reserved. A United Business Media company.